Is Age Just a "Number" When Evaluating the Efficacy and Safety of Triple-Inhaled Therapy in COPD?

Chest. 2021 Mar;159(3):895-896. doi: 10.1016/j.chest.2020.10.022.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenergic beta-2 Receptor Agonists*
  • Humans
  • Muscarinic Antagonists
  • Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Muscarinic Antagonists